Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Takeda files for ED treatment in Europe

Jan. 27, 2000

Novel, highly water soluble salt of sildenafil suitable for intranasal administration

Jan. 26, 2000

New inhibitors of cGMP-PDE in development at BMS for ED and cardiovascular conditions

Jan. 24, 2000

Melanocortin receptor agonists and their use disclosed by Merck

Jan. 21, 2000

Afferon steps up development of RTX for treatment of urge incontinence

Jan. 21, 2000

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Jan. 19, 2000

Pharmacia & Upjohn and Searle to copromote Detrol

Jan. 11, 2000

FDA informs Urologix of new developments concerning the Targis System

Jan. 6, 2000

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

Once-daily oxybutynin assessed in urinary urge incontinence

Dec. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.